JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration. NEXT EVENTS:
Thursday 9th February 2017Dissolution testing: current and future considerationsRoyal Society of Chemistry, London
Dissolution and disintegration tests for solid oral dosage forms provide insight into the rate of release of the drug into the body. Dissolution has been viewed solely as a quality control tool, but more recently this view has started to change and now there is clear expectation that dissolution must have clinical relevance.
However, the challenge remains: how can a single test be sensitive enough to predict changes that may be of clinical relevance, whilst being robust enough to satisfy the needs of a quality control environment?
This symposium will explore the current state of these techniques from a regulatory, pharmacopoeia, academic and industry perspective, and how emerging bio-relevant dissolution tools can improve our prediction of oral drug behaviour.
This symposium should be attractive to scientists working in research & development, quality control, regulatory, pharmacopoeias and academia. In addition senior managers will benefit from attending. This symposium is organised in association with the OrBiTo consortium.
Dr Karl Box - Sirius Analytical
Dr Karin Bracht - MHRA
Dr James Butler - GlaxoSmithKline
Dr David Elder - JPAG/Consultant
Dr Edmund Kostewicz - Frankfurt University
Dr James Mann - AstraZeneca
Catherine Pitt - MHRA
Dr Axel Zeitler - Cambridge UniversityDETAILS AND BOOKING
Thursday 16th March 2017Assuring data integrity; best practiceRoyal Society of Chemistry, London
Data integrity is receiving much attention in the pharmaceutical industry, with several high profile cases where deficiencies have resulted in regulatory action, and the MHRA, FDA, EMA and WHO have all issued guidance documents recently.
This symposium will bring together experts from Health Authorities, pharmaceutical companies, CROs and technology -providers to discuss the approaches being taken to rise to the challenge of increased scrutiny of data management practices.
Mr Dean Harris, Envigo
Mr Paul Smith, Agilent
Dr Adrian Davis, Pfizer R&D
Dr Gerhard Noelken, Data4LabDETAILS AND BOOKING
Thursday 16th March 2017Annual General MeetingRoyal Society of Chemistry, LondonDETAILS AND BOOKING LAST EVENT: Thursday 1st December 2016Regulatory Hot Topics IIRoyal Society of Chemistry, London
This one-day symposium will address issues and challenges associated with the implementation of new and emerging guidelines.
It will provide the opportunity for dialogue and discussion through an effective forum to understand, interpret and translate into day-to-day practice on topics including: ICH Q3D; ICH Q12; continuous manufacture; excipient GMP; allowable flexibility in analytical methods; development and filing of a breakthrough status medicine; microbiological quality of non-sterile dosage forms (USP 1111 and 1115)DETAILS
Follow and Like us on Social media
Delegates of any JPAG symposia can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST MEETINGS 2011-present. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical ReviewTESTIMONIALS:Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made (March 2015)
JPAG members can receive a free hard copy subscription to EPRclick here
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs (June 2015)
Excipient quality and supplier inter-changeability
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Excipient quality and supplier inter-changeability", written by Martin Kuentz, University of Applied Sciences and Arts Nort...More...Saturday 29th October 2016
Interpreting ICH s evolving residual solvents guideline
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled “Interpreting ICH s evolving residual solvents guideline”, written by Dr Dave Elder, Chairman of the JPAG Committee. More...Saturday 29th October 2016
Modern pharmaceutical manufacturing
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Modern pharmaceutical manufacturing" written by Dr Dave Elder, Chairman of the JPAG Committee. More...Friday 28th October 2016
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).